- Published on
Infectious Disease And Microbiology – Encephalitis
Encephalitis is an inflammation of the brain parenchyma that leads to neurological dysfunction and is most commonly caused by infections. These infections may be viral, bacterial, fungal, or protozoal, with viruses being the most frequent cause. The condition typically arises when pathogens spread to the central nervous system via the bloodstream, although some, such as rabies, travel through peripheral nerves. Clinically, encephalitis often presents with fever, headache, confusion, and altered mental status, and may also involve seizures or focal neurological deficits.
Epidemiologically, encephalitis affects both extremes of age, particularly the very young and the elderly. Viral encephalitis is the most common form, with an annual incidence of approximately 3.5–7.4 cases per 100,000 people, accounting for around 20,000 new cases each year. In the United States, herpes simplex virus (HSV) is the leading identifiable cause, responsible for about 10% of all cases. In neonates, HSV-2 is the most common cause and is typically acquired during delivery. In many cases—up to 75%—no specific causative agent is identified.
Risk factors for encephalitis include age, immune status, seasonal exposure, and environmental or travel-related exposures. Arboviral infections are more common during summer and fall, while HSV infections occur year-round. Exposure to mosquitoes, ticks, animals, or contaminated water sources increases risk. Preventive strategies include avoiding insect bites, implementing vector control measures, and vaccination against preventable viral causes such as measles, mumps, rubella, polio, varicella, and Japanese encephalitis.
The pathophysiology varies depending on the causative organism but generally involves viremia followed by invasion of the central nervous system. This leads to inflammation, neuronal injury, and sometimes necrosis. In HSV encephalitis, the temporal lobes are commonly affected, whereas other viruses may target different brain regions such as the brainstem or gray matter.
Etiologically, encephalitis has a broad range of causes. Viral pathogens include herpesviruses (HSV, CMV, VZV), arboviruses (e.g., West Nile virus, Japanese encephalitis virus), enteroviruses, rabies virus, and HIV. Bacterial causes include Listeria monocytogenes, Mycobacterium tuberculosis, and Mycoplasma. Other causes include rickettsial organisms, spirochetes such as Borrelia burgdorferi, fungi like Cryptococcus neoformans, and protozoa such as Toxoplasma gondii and Naegleria fowleri. Helminths such as Taenia solium may also be implicated.
Diagnosis relies heavily on clinical suspicion, supported by history and examination. Important historical clues include recent travel, insect or animal exposure, and immune status. Physical examination focuses on neurological findings, though skin examination may reveal rashes that help identify specific etiologies. Because encephalitis may overlap clinically with meningitis, distinguishing between the two can be challenging.
Laboratory evaluation includes cerebrospinal fluid (CSF) analysis obtained via lumbar puncture, which typically shows lymphocytic pleocytosis, elevated protein, and normal glucose in viral cases. PCR testing of CSF is essential for identifying viral pathogens such as HSV, CMV, and VZV. Additional tests may include serology, blood cultures, and pathogen-specific assays depending on clinical suspicion. Imaging is critical, with brain MRI being the gold standard; characteristic findings such as temporal lobe involvement suggest HSV encephalitis. CT scanning is useful when MRI is unavailable or to rule out contraindications to lumbar puncture.
The differential diagnosis is broad and includes meningitis, brain abscess, encephalopathy, acute disseminated encephalomyelitis, metabolic disorders, vasculitis, and drug-induced aseptic meningitis. Management requires prompt empiric therapy. Until bacterial meningitis is excluded, patients should receive broad antimicrobial coverage along with antiviral therapy. Intravenous acyclovir is the treatment of choice for suspected HSV encephalitis and should be started immediately. Other antiviral or antimicrobial treatments depend on the identified pathogen, and adjunctive therapies such as antiretroviral treatment may be required in HIV-related cases.
Patients with encephalitis require hospitalization, often with intensive care monitoring. Supportive care includes adequate hydration, especially during acyclovir therapy to prevent renal toxicity. Close monitoring is essential, as recovery may be prolonged and incomplete.
The prognosis of encephalitis varies widely depending on the causative organism and timeliness of treatment. HSV encephalitis, if untreated, carries a mortality rate of up to 70%, but early treatment reduces mortality to 6–19%. However, many survivors experience long-term neurological deficits. Younger patients tend to have better outcomes.
Complications of encephalitis include seizures, permanent neurological impairment, relapse (particularly in HSV infection), and death. Long-term follow-up may involve neuropsychological assessment to evaluate cognitive and functional outcomes.
Encephalitis is an inflammation of the brain parenchyma that leads to neurological dysfunction and is most commonly caused by infections. These infections may be viral, bacterial, fungal, or protozoal, with viruses being the most frequent cause. The condition typically arises when pathogens spread to the central nervous system via the bloodstream, although some, such as rabies, travel through peripheral nerves. Clinically, encephalitis often presents with fever, headache, confusion, and altered mental status, and may also involve seizures or focal neurological deficits.
Epidemiologically, encephalitis affects both extremes of age, particularly the very young and the elderly. Viral encephalitis is the most common form, with an annual incidence of approximately 3.5–7.4 cases per 100,000 people, accounting for around 20,000 new cases each year. In the United States, herpes simplex virus (HSV) is the leading identifiable cause, responsible for about 10% of all cases. In neonates, HSV-2 is the most common cause and is typically acquired during delivery. In many cases—up to 75%—no specific causative agent is identified.
Risk factors for encephalitis include age, immune status, seasonal exposure, and environmental or travel-related exposures. Arboviral infections are more common during summer and fall, while HSV infections occur year-round. Exposure to mosquitoes, ticks, animals, or contaminated water sources increases risk. Preventive strategies include avoiding insect bites, implementing vector control measures, and vaccination against preventable viral causes such as measles, mumps, rubella, polio, varicella, and Japanese encephalitis.
The pathophysiology varies depending on the causative organism but generally involves viremia followed by invasion of the central nervous system. This leads to inflammation, neuronal injury, and sometimes necrosis. In HSV encephalitis, the temporal lobes are commonly affected, whereas other viruses may target different brain regions such as the brainstem or gray matter.
Etiologically, encephalitis has a broad range of causes. Viral pathogens include herpesviruses (HSV, CMV, VZV), arboviruses (e.g., West Nile virus, Japanese encephalitis virus), enteroviruses, rabies virus, and HIV. Bacterial causes include Listeria monocytogenes, Mycobacterium tuberculosis, and Mycoplasma. Other causes include rickettsial organisms, spirochetes such as Borrelia burgdorferi, fungi like Cryptococcus neoformans, and protozoa such as Toxoplasma gondii and Naegleria fowleri. Helminths such as Taenia solium may also be implicated.
Diagnosis relies heavily on clinical suspicion, supported by history and examination. Important historical clues include recent travel, insect or animal exposure, and immune status. Physical examination focuses on neurological findings, though skin examination may reveal rashes that help identify specific etiologies. Because encephalitis may overlap clinically with meningitis, distinguishing between the two can be challenging.
Laboratory evaluation includes cerebrospinal fluid (CSF) analysis obtained via lumbar puncture, which typically shows lymphocytic pleocytosis, elevated protein, and normal glucose in viral cases. PCR testing of CSF is essential for identifying viral pathogens such as HSV, CMV, and VZV. Additional tests may include serology, blood cultures, and pathogen-specific assays depending on clinical suspicion. Imaging is critical, with brain MRI being the gold standard; characteristic findings such as temporal lobe involvement suggest HSV encephalitis. CT scanning is useful when MRI is unavailable or to rule out contraindications to lumbar puncture.
The differential diagnosis is broad and includes meningitis, brain abscess, encephalopathy, acute disseminated encephalomyelitis, metabolic disorders, vasculitis, and drug-induced aseptic meningitis. Management requires prompt empiric therapy. Until bacterial meningitis is excluded, patients should receive broad antimicrobial coverage along with antiviral therapy. Intravenous acyclovir is the treatment of choice for suspected HSV encephalitis and should be started immediately. Other antiviral or antimicrobial treatments depend on the identified pathogen, and adjunctive therapies such as antiretroviral treatment may be required in HIV-related cases.
Patients with encephalitis require hospitalization, often with intensive care monitoring. Supportive care includes adequate hydration, especially during acyclovir therapy to prevent renal toxicity. Close monitoring is essential, as recovery may be prolonged and incomplete.
The prognosis of encephalitis varies widely depending on the causative organism and timeliness of treatment. HSV encephalitis, if untreated, carries a mortality rate of up to 70%, but early treatment reduces mortality to 6–19%. However, many survivors experience long-term neurological deficits. Younger patients tend to have better outcomes.
Complications of encephalitis include seizures, permanent neurological impairment, relapse (particularly in HSV infection), and death. Long-term follow-up may involve neuropsychological assessment to evaluate cognitive and functional outcomes.
0 Comments
